6Abe M,Akbar F,Hasebe A,et al.Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis.J Gastroenterol,2003,38:962-967.
7Dai JH,Iwatani Y,Ishida,et al.Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages.Immunology,2001,103:235-243.
9Van Rossum TG,VuhoAG,De Man RA,et al.Review article:glycyrrhizin as a potential treatment for chronic hepatitis C.Aliment Pharmacol Ther,1998,12:199-205.
10Tandon A,Tandon BN,Bhujwala RA.Clinical spectrum of acute sporadic hepatitis E and possible benefit of glyeyrrhizin therapy.Hepatol Res,2002,23:55-61.
5BROWN DB,PILGRAM TK,DARCY MD,et al.Hepatic arteri-al chemoembolization for hepatocellular carcinoma:Comparison ofsurvival rates with different embolic agents[J].J Vasc Interv Ra-diol,2005,16(12):1661-1666.
6GOMES AS,ROSOVE MH,ROSEN PJ,et al.Triple-drug tran-scatheter arterial chemoembolization in unresectable hepatocellu-lar carcinoma:assessment of survival in 124 consecutive patients[J].Am J Roentgenol,2009,193(6):1665-1671.
7MURATA S,TAJIMA H,ICHIKAWA K,et al.Oily chemoem-bolization combined with degradable starch microspheres for HCCwith cirrhosis[J].Hepatogastroenterology,2008,55(84):1041-1046.
8JARNAGIN W,DEMATTEO R,BLUMGAR LH,et al.Tran-scatheter arterial embolization with only particles for the treatmentof unresectable hepatocellular carcinoma[J].J Vasc Interv Radi-ol,2008,19(6):862-869.
